Emblem (EMMBF) Stock Price, News & Analysis

Company Overview

Emblem Health Sciences Inc., trading under the symbol EMMBF on the OTC Markets, is a vertically integrated cannabis company headquartered in Niagara-on-the-Lake, Ontario. Founded in 2017, the company holds licences from Health Canada for cultivation, processing, and sale of medical cannabis. Emblem’s approach emphasizes research-driven product development and quality assurance, with in-house laboratories that oversee every stage of production to ensure compliance with Good Manufacturing Practices (GMP) and provincial regulations.

The company’s product portfolio spans dried flower, cannabis oils, softgel capsules, and pre-rolled offerings tailored to medical and recreational consumers. Emblem has introduced proprietary formulations designed for specific therapeutic outcomes, including formulations targeted at pain management, stress relief, and sleep support. To support innovation, the company maintains partnerships with academic institutions and undertakes clinical research to validate product efficacy and safety profiles.

Emblem serves markets across Canada’s medical cannabis landscape and has secured export permits to supply international markets in Europe and Latin America. The company operates multiple state-of-the-art cultivation greenhouses and indoor growing facilities, featuring environmentally controlled environments and advanced irrigation systems to optimize yield and cannabinoid profiles. Emblem’s distribution network includes both direct-to-patient channels and partnerships with licensed producers, pharmacies, and health-care institutions.

Leadership at Emblem comprises executives with experience in pharmaceuticals, agriculture, and regulatory affairs. CEO Jay Czahor brings expertise in bio-agriculture and corporate strategy, while CFO Christopher Leach oversees financial planning and investor relations. The management team’s depth in compliance, research, and supply-chain logistics positions Emblem to meet evolving regulatory requirements and expanding demand for high-quality, science-backed cannabis products.

Key Stats

• Today's Range: $1.36 to $1.45
• 50-Day Range: $1.40 to $1.40
• 52-Week Range: $0.60 to $1.63
• Volume: 156,200 shs
• Average Volume: 280,719 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMMBF Stock Analysis - Frequently Asked Questions

How have EMMBF shares performed this year?

Emblem's stock was trading at $1.40 on January 1st, 2025. Since then, EMMBF stock has increased by 0.0% and is now trading at $1.40.

How do I buy shares of Emblem?

Shares of EMMBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EMMBF
• CIK: N/A
• Web: emblemcorp.com
• Phone: (416) 962-3300
• Fax: N/A
• Employees: 74
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A